Latest Strategic Partnerships News

GreenHy2 Limited has launched its PowerSafe Sodium-Ion Battery range tailored for Australian conditions, expanded into turnkey solar and battery solutions, and signed a strategic MOU with Skeleton Technologies to explore advanced energy storage in Australia.

Axiom Properties Limited reports strong growth in its PaySure division, launches a new Settlement Advance product, and secures $1 million in fresh capital as it prepares to rebrand as Axtec Limited.

Morella Corporation’s September quarter report reveals significant progress in its diversified critical minerals portfolio, including new titanium-vanadium exposure and streamlined US lithium assets. The company is gearing up for drilling and resource definition in 2026, supported by strengthened funding.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.

Nelson Resources confirms high-grade gold assay results at its Yarri Project and partners with MEGA Resources to fully fund and manage development operations.

Scorpion Minerals Limited has resumed trading following a pivotal announcement on drilling results, a new tenement application, and a potential strategic partnership, alongside financing updates.

Scorpion Minerals reports promising shallow gold intercepts at its Pharos Project and announces a strategic collaboration with Gylden Resources, enhancing processing options in Western Australia’s Murchison region.

Ioneer Ltd has enhanced the economics of its Rhyolite Ridge Lithium-Boron Project by cutting leach retention time, boosting lithium and boron production and improving key financial metrics with minimal capital cost increase.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Great Southern Mining has sold a key mining license to Regis Resources for up to A$9 million and is progressing multiple drilling programs across its Australian projects, supported by government grants and a strategic alliance.